ACUTAAS
Acutaas Chemicals Limited
Each stock's 10,000-path forecast, rendered as light.
Acutaas Chemicals Limited (ACUTAAS) Stock Analysis & Case Study
Is ACUTAAS a good buy? The data-driven verdict.
Acutaas Chemicals Limited (ACUTAAS) trades at ₹3,298,on the numbers it mixed signals, a Downstox Snapshot Score of 47/100.
On the numbers, Acutaas Chemicals Limited (ACUTAAS) mixed signals, a Downstox Snapshot Score of 47/100, weighing expensive at 69.9× earnings, ROE of 24.0%, a 52% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
ACUTAAS fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How ACUTAAS ranks against the 2,373 companies in our screener
- ACUTAAS's market cap of 27,000 Cr ranks in the 87th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ACUTAAS's book value of ₹202 ranks in the 72nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ACUTAAS's promoter holding of 32.7% ranks in the 10th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ACUTAAS's 3-year profit (PAT) growth of 62.0% ranks in the 87th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ACUTAAS's 3-year revenue growth of 30.0% ranks in the 85th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ACUTAAS's debt-to-equity ratio of 0.02x is lower than 94% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is ACUTAAS overvalued? ACUTAAS P/E vs peers
ACUTAAS trades at 69.9× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
ACUTAAS share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 4.8y of ACUTAAS history (41%/yr drift, 47%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| ACUTAAS 2027 | ₹1,849 | ₹3,354 | ₹6,085 | +2% |
| ACUTAAS 2028 | ₹1,474 | ₹3,412 | ₹7,894 | +3% |
| ACUTAAS 2029 | ₹1,225 | ₹3,470 | ₹9,831 | +5% |
| ACUTAAS 2030 | ₹1,050 | ₹3,529 | ₹11,864 | +7% |
| ACUTAAS 2031 | ₹930 | ₹3,589 | ₹13,857 | +9% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability ACUTAAS goes up, or doubles?
The bull case for ACUTAAS
- ACUTAAS's return on equity of 24.0% ranks in the 89th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- ACUTAAS's return on capital employed of 31.6% ranks in the 94th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹9,831.
The bear case & risks
- ACUTAAS's P/E of 69.9x is lower than 17% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- A steep 16.3× price-to-book means most of the value is intangible/expectations, not assets on the books.
- High historical volatility (47%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹1,225.
ACUTAAS volatility & expected range, how bumpy is the ride?
Over the last 4.8 years ACUTAAS compounded at 41%/year with annualized volatility of 47%. That volatility implies a 1-year 80% range of ₹1,849-₹6,085, the honest backbone behind any single price target.
ACUTAAS price forecast, the full 60-month probability fan
ACUTAAS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds ACUTAAS hits common targets within the simulated horizon?
Full multi-horizon detail on the ACUTAAS price target & forecast page.
ACUTAAS Piotroski F-Score: 6/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. ACUTAAS scores 6/8, mixed financial health.
ACUTAAS MTF margin & leverage across 8 brokers
Margin Trading Facility lets you buy ACUTAAS with part of the capital. Lower margin % = higher leverage. Rates compared across 8 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Zerodha | 36.26% | 2.8× |
| Groww | 60.00% | 1.7× |
| Kotak NeoCHEAPEST | 36.23% | 2.8× |
| Paytm Money | 100.00% | 1.0× |
| Pocketful | 36.37% | 2.7× |
| Fyers | 100.00% | 1.0× |
| Anand Rathi | 100.00% | 1.0× |
| Share India | 36.37% | 2.7× |
Compare every broker on the ACUTAAS MTF page.
About Acutaas Chemicals Limited: sector, index & market-cap context
Acutaas Chemicals Limited (ACUTAAS) is a mid-cap NSE-listed company, and a constituent of the Nifty 500 index, with a market capitalisation of ₹27,000 Cr. See more stocks on our screener.
How the ACUTAAS Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Acutaas Chemicals Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
ACUTAAS analysis, FAQs
Is Acutaas Chemicals Limited (ACUTAAS) a good buy?
On the numbers, Acutaas Chemicals Limited (ACUTAAS) mixed signals, a Downstox Snapshot Score of 47/100, weighing expensive at 69.9× earnings, ROE of 24.0%, a 52% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is ACUTAAS overvalued or undervalued?
ACUTAAS trades at 69.9× earnings, expensive versus the ~22× long-run Nifty average.
What is the ACUTAAS share price target for 2031?
ACUTAAS's probability-weighted 2031 median target is ₹3,589, with an 80% range of ₹930-₹13,857 (10,000-path Monte-Carlo).
What is the probability ACUTAAS doubles in 5 years?
The modelled probability of ACUTAAS reaching ₹6,596 (2×) within 5 years is 28%.
What is the bull case for ACUTAAS?
ACUTAAS's return on equity of 24.0% ranks in the 89th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. ACUTAAS's return on capital employed of 31.6% ranks in the 94th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in ACUTAAS?
ACUTAAS's P/E of 69.9x is lower than 17% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. A steep 16.3× price-to-book means most of the value is intangible/expectations, not assets on the books. High historical volatility (47%/yr) means a wide, bumpy range of outcomes, size positions accordingly.